Value Sense
OSCR
Oscar Health, Inc. (OSCR)
Last Price$15.13.3%
Market Cap$3,703.3M
LTM Cash & Cash Equivalents
$1,527.2M
YoY Growth
-18.3%
3Y CAGR
+11.4%
5Y CAGR
N/A
Stock quality & Intrinsic value
6/10
57.0% undervalued
OSCR
is 57.0% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Oscar Health, Inc. Cash & Cash Equivalents

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Cash & Cash Equivalents
$336.6M
$826.3M
$1,104.0M
$1,558.6M
$1,870.3M
$1,527.2M
OSCR
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for OSCR and see if it's the right time to invest.
Dive in

Oscar Health, Inc. (OSCR) Cash & Cash Equivalents comparison analysis

General

LTM Cash & Cash Equivalents

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
$1,527.2M
(18.3%)
11.4%
N/A
Median Peer Set
$6,106.0M
0.6%
(0.4%)
9.5%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
$29.1B
14.5%
10.8%
21.5%
Centene Corporation logo
Centene CorporationCNC
$14.1B
(18.2%)
2.3%
3.0%
CVS Health Corporation logo
CVS Health CorporationCVS
$8,586.0M
4.8%
(3.0%)
8.6%
Elevance Health Inc. logo
Elevance Health Inc.ELV
$8,288.0M
27.0%
19.3%
10.9%
Cigna Corporation logo
Cigna CorporationCI
$7,550.0M
(3.5%)
14.1%
10.3%
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
$4,662.0M
(3.8%)
1.7%
13.7%
Humana Inc. logo
Humana Inc.HUM
$2,221.0M
(52.7%)
(13.2%)
(11.3%)
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
$432.9M
113.3%
(2.5%)
N/A
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
$194.5M
58.3%
(13.4%)
23.5%
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
$87.3M
(81.3%)
(43.7%)
N/A

OSCR key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
553.8
0.0%
589.6
6.5%
1,921.0
225.8%
4,125.6
114.8%
5,862.9
42.1%
9,177.6
56.5%
Cost of Goods Sold (COGS)0.00.00.00.00.00.0
Gross Profit
% margin
553.8
100.0%
589.6
100.0%
1,921.0
100.0%
4,125.6
100.0%
5,862.9
100.0%
9,177.6
100.0%
Operating Expenses(814.2)(996.5)(2,498.0)4,553.56,098.59,120.3
Research & Development Expenses (R&D)0.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)110.7166.7265.1309.8339.71,755.9
Operating Income
% margin
(260.5)
(47.0%)
(406.9)
(69.0%)
(577.1)
(30.0%)
(584.2)
(14.2%)
(235.6)
(4.0%)
57.3
0.6%
Interest Income11.18.010.331.30.00.0
Interest Expense0.03.54.722.624.623.7
Pre-tax Income(259.4)(405.8)(570.6)(610.1)(267.3)33.4
Income Tax
% effective tax rate
1.8
(0.7%)
1.0
(0.3%)
0.8
(0.1%)
(0.5)
0.1%
3.3
(1.2%)
7.3
21.9%
Net Income
% margin
(261.2)
(47.2%)
(406.8)
(69.0%)
(571.4)
(29.7%)
(609.6)
(14.8%)
(270.7)
(4.6%)
25.4
0.3%
EPS(1.09)(1.70)(3.19)(2.87)(1.22)0.11
Diluted EPS(1.09)(1.70)(3.19)(2.87)(1.22)0.10
EBITDA
% margin
(252.5)
(45.6%)
(391.0)
(66.3%)
(551.3)
(28.7%)
(572.2)
(13.9%)
(212.0)
(3.6%)
88.6
1.0%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Oscar Health, Inc.'s Cash & Cash Equivalents?

As of today, Oscar Health, Inc.'s last 12-month Cash & Cash Equivalents is $1,527.2M, based on the financial report for Dec 31, 2024 (Q4’2024).

2) What is Oscar Health, Inc.'s Cash & Cash Equivalents growth rate?

Over the last year, Oscar Health, Inc.'s Cash & Cash Equivalents growth was (18.3%). The average annual Cash & Cash Equivalents growth rates for Oscar Health, Inc. have been (3.0%) over the past three years, N/A over the past five years.

3) Is Oscar Health, Inc.'s Cash & Cash Equivalents growth rate Good?

Over the last year, Oscar Health, Inc.'s Cash & Cash Equivalents growth was (18.3%), which is lower than industry growth of (0.3%). It indicates that Oscar Health, Inc.'s Cash & Cash Equivalents growth is Bad.

4) How does Oscar Health, Inc.'s Cash & Cash Equivalents growth rate compare to its peers?

Over the last year, Oscar Health, Inc.'s Cash & Cash Equivalents growth was (18.3%), which is lower than peer median growth of 7.4%. The list of peers includes UNH, CNC, CVS, ELV, CI, MOH, HUM, ALHC, CLOV, BHG etc.